Zimmer® Natural Nail® (ZNN) Bactiguard Tibia Post-Market Clinical Follow-up Study
Performance, Safety and Clinical Benefits of a Noble Metal Alloy-coated Intramedullary Nail: a Multicenter, Prospective Trial With a Retrospective Control
Sponsor: Zimmer Biomet
Listed as NCT05022485, this observational or N/A phase trial focuses on Fracture Infection and Tibial Fractures and remains actively recruiting participants. Sponsored by Zimmer Biomet, it has been updated 10 times since 2022, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
10 versions recorded-
Dec 2025 — Present [monthly]
Recruiting
-
Sep 2025 — Dec 2025 [monthly]
Recruiting
-
Jan 2025 — Sep 2025 [monthly]
Recruiting
-
Sep 2024 — Jan 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
▶ Show 5 earlier versions
-
Apr 2024 — Jul 2024 [monthly]
Recruiting
-
Aug 2023 — Apr 2024 [monthly]
Recruiting
-
Jun 2022 — Aug 2023 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Feb 2022 — Jun 2022 [monthly]
Not Yet Recruiting
-
Sep 2021 — Feb 2022 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Zimmer Biomet
For direct contact, visit the study record on ClinicalTrials.gov .